Amblyopia Clinical Trial
Official title:
The Effect of Donepezil on Perceptual Learning in Adult Amblyopia
The research deals with amblyopia or lazy eye, a condition that affects about 3% of the population, and results in a variety of visual deficits. Recent work suggests that there is limited neural plasticity in the visual system of adults with amblyopia. This study is aimed at understanding and increasing this plasticity. In this study, the investigators aim to understand how the amblyopic brain learns and how this process is affected by a drug called donepezil, which is sometimes given as a treatment for Alzheimer's disease. The investigators hope that this study will help to identify the chemical components that help the brain to learn, as well as the mechanism of amblyopia. The investigators also plan to test the normal periphery, as control.
The research deals with amblyopia or lazy eye, a condition that affects about 3% of the
population, and results in a variety of visual deficits. Recent work suggests that there is
limited neural plasticity in the visual system of adults with amblyopia. This study is aimed
at understanding and increasing this plasticity. In this study, the investigators aim to
understand how the amblyopic brain learns and how this process is affected by a drug called
donepezil, which is sometimes given as a treatment for Alzheimer's disease. The investigators
hope that this study will help to identify the chemical components that help the brain to
learn, as well as the mechanism of amblyopia. The investigators also plan to test the normal
periphery, as control.
In this study, donepezil will be administered while amblyopic subjects (or normally sighted
subjects tested in the periphery) are trained on a low-contrast single-letter recognition
task, or an uncrowd task (recognizing a letter closely embedded within two other letters).
Subjects will be asked to identify the target letter (the low-contrast single letter, or the
letter embedded within other letters). Training will take place for 10 consecutive days. Pre-
and post-tests will be conducted immediately before and after training, and will consist of
the measurements of visual acuity, crowding extent and contrast threshold for recognizing
single letters.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04238065 -
A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia
|
N/A | |
Completed |
NCT04432181 -
Comparison of Deviation Types Among Astigmatic Children With Or Without Amblyopia
|
||
Terminated |
NCT02767856 -
Regimens of Intermittent Occlusion Therapy for Amblyopia in Children
|
N/A | |
Completed |
NCT02458846 -
Efficacy of Visual Screening in Ontario
|
N/A | |
Completed |
NCT01190813 -
Levodopa for the Treatment of Residual Amblyopia
|
Phase 3 | |
Completed |
NCT01109459 -
Multimodal Physician Intervention to Detect Amblyopia
|
N/A | |
Completed |
NCT04313257 -
Monocular Action Video Game Treatment of Amblyopia
|
N/A | |
Completed |
NCT04315649 -
Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops
|
N/A | |
Completed |
NCT05223153 -
OCT-A and Amblyopia
|
||
Recruiting |
NCT05522972 -
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
|
N/A | |
Completed |
NCT01430247 -
Vision Screening for the Detection of Amblyopia
|
N/A | |
Completed |
NCT02200211 -
Study of Binocular Computer Activities for Treatment of Amblyopia
|
N/A | |
Recruiting |
NCT06429280 -
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
|
||
Withdrawn |
NCT04959422 -
Assuring Ophthalmologic Follow up
|
N/A | |
Active, not recruiting |
NCT05612568 -
5 Years of Eye Screening for ARF in Children Aged <3 Years in Flanders
|
||
Recruiting |
NCT03655912 -
Binocular Visual Therapy and Video Games for Amblyopia Treatment.
|
N/A | |
Recruiting |
NCT06150391 -
Evaluation of Amblyopia Protocols Using a Dichoptic Gabor Videogame Program
|
N/A | |
Completed |
NCT03754153 -
Binocularly Balanced Viewing Study
|
N/A | |
Terminated |
NCT02246556 -
Dichoptic Virtual Reality Therapy for Amblyopia in Adults
|
Phase 1 | |
Withdrawn |
NCT02594358 -
Caffeine in Amblyopia Study
|
Phase 1/Phase 2 |